Massive Bio As

Early detection only delivers on its promise when it opens doors to the best available care.

5-year survival rates for lung cancer rise from 9% when caught late — to 64% when caught early. But most high-risk patients still never reach a clinical trial.

Massive Bio and Optellum are working to change that. Our new collaboration connects Optellum's FDA-cleared AI, which identifies high-risk lung cancer patients before a formal diagnosis is confirmed, to Massive Bio's clinical trial matching platform, so patients are considered for active trials at exactly the right moment in their care journey.

Earlier identification. Smarter matching. No delays.

https://massivebio.com/massive-bio-optellum-nsclc-clinical-trial-access/?utm_source=facebook&utm_medium=organic&utm_campaign=optellum-partnership&utm_content=announcement-post

Finding the right clinical trial can change everything for a cancer patient. But for too many, that connection never happens.

Massive Bio has partnered with TOUCH, The Black Breast Cancer Alliance and Navigating Trials to change that. Our AI-powered matching is now embedded directly into the communities patients already trust, so no one misses a trial that could matter.

Read the full announcement: https://massivebio.com/massive-bio-touch-bbca-navigating-trials?utm_source=facebook&utm_medium=organic&utm_campaign=touch-bbca-navigating-trials-pr

We're expanding access to oncology clinical trials for underserved communities, with privacy built in from the start.

Massive Bio has deployed its AI-powered pre-screening capabilities through BeeKeeperAI's EscrowAI® platform, leveraging federated confidential computing to match cancer patients to clinical trials without ever moving their sensitive data outside the healthcare provider's environment.

The program initially focuses on the Atlanta, Georgia region, working to reach historically underrepresented patient populations who may otherwise never learn about trials they qualify for.

This is what equitable, scalable clinical research looks like: AI traveling to the data, not the other way around.

🔗 Read the full announcement: https://massivebio.com/massive-bio-beekeeperai-collaboration?utm_source=facebook&utm_medium=organic&utm_campaign=massive-bio-beekeeperai-collaboration

Happy Mother's Day! 💙

To all the moms who loved fiercely, sacrificed quietly, and showed up every single day, today is for you.

At Massive Bio, everything we do comes back to keeping families together. Connecting cancer patients to the right clinical trials means more time, more hope, and more moments that matter.

Wishing a beautiful day to every mother and every family celebrating today.